PH Pharma, which could not exceed the threshold of the KOSDAQ preliminary examination last year, plans to re-challenge this year’s IPO.
(For more information, please refer to the link below)
http://www.thebell.co.kr/free/Content/ArticleView.asp?key=202101081242287200105995